triazoles has been researched along with Apparent Mineralocorticoid Excess Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inderbinen, SG; Kley, M; Odermatt, A; Smieško, M; Zogg, M | 1 |
| Chang, D; McHardy, I; Semrad, A; Thompson, GR; Wittenberg, RR | 1 |
| Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ | 1 |
| McKinnon, M; Reimer, EK; Stock, W; Wassermann, T | 1 |
4 other study(ies) available for triazoles and Apparent Mineralocorticoid Excess Syndrome
| Article | Year |
|---|---|
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Itraconazole; Mineralocorticoid Excess Syndrome, Apparent; Protein Conformation; Species Specificity; Structure-Activity Relationship; Triazoles; Zebrafish Proteins | 2021 |
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aged; Antifungal Agents; Cortisone; Humans; Hydrocortisone; Hypertension; Hypokalemia; Lung; Male; Mineralocorticoid Excess Syndrome, Apparent; Pulmonary Aspergillosis; Triazoles | 2017 |
Posaconazole-Induced Pseudohyperaldosteronism.
Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole | 2018 |
Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole.
Topics: Aged; Female; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Mineralocorticoid Excess Syndrome, Apparent; Potassium; Triazoles | 2018 |